Theresa Medina, MD, discusses the clinical potential of lifileucel, a tumor-infiltrating lymphocyte therapy, for patients with advanced melanoma.

Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.

Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a study finds.